Literature DB >> 15316699

Substantia innominata: MR findings in Parkinson's disease.

Hirobumi Oikawa1, Makoto Sasaki, Shigeru Ehara, Takashi Abe.   

Abstract

To elucidate MR imaging changes of the substantia innominata in Parkinson's disease (PD), using a 1.5-T superconductive MR unit, the thickness of the substantia innominata was measured on coronal thin-section images in 44 PD patients and 20 age-matched control subjects. We also evaluated the correlation between the thickness of the substantia innominata and mental status in PD patients. Mean thickness of the substantia innominata was 2.3 mm in PD patients, and 2.5 mm in control subjects. Thinning of the substantia innominata was statistically significant in PD patients compared with control subjects, although there were large overlaps. Among the PD patients, thinning was remarkable in cases with dementia. A positive correlation between thickness of substantia innominata and score of Mini-Mental-Status-Examination was also observed in PD patients. Atrophy of the substantia innominata was demonstrated, especially in PD patients with cognitive impairment, on coronal MR images, and this is compatible with the previous pathological reports.

Entities:  

Mesh:

Year:  2004        PMID: 15316699     DOI: 10.1007/s00234-004-1257-4

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  20 in total

1.  Alzheimer's neurofibrillary changes. A topographic study.

Authors:  A HIRANO; H M ZIMMERMAN
Journal:  Arch Neurol       Date:  1962-09

2.  Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson's disease and Alzheimer's disease.

Authors:  P J Whitehouse
Journal:  Adv Neurol       Date:  1987

3.  Selective loss of central cholinergic neurons in Alzheimer's disease.

Authors:  P Davies; A J Maloney
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321

4.  Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey.

Authors:  M M Mesulam; E J Mufson; A I Levey; B H Wainer
Journal:  J Comp Neurol       Date:  1983-02-20       Impact factor: 3.215

5.  Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis.

Authors:  P J Whitehouse; D L Price; A W Clark; J T Coyle; M R DeLong
Journal:  Ann Neurol       Date:  1981-08       Impact factor: 10.422

6.  Magnetisation transfer measurements of the subcortical grey and white matter in Parkinson's disease with and without dementia and in progressive supranuclear palsy.

Authors:  H Hanyu; T Asano; H Sakurai; M Takasaki; H Shindo; K Abe
Journal:  Neuroradiology       Date:  2001-07       Impact factor: 2.804

7.  A subcortico-cortical cholinergic system is affected in Parkinson's disease.

Authors:  B Dubois; M Ruberg; F Javoy-Agid; A Ploska; Y Agid
Journal:  Brain Res       Date:  1983-12-12       Impact factor: 3.252

8.  MR anatomy of the substantia innominata and findings in Alzheimer disease: a preliminary report.

Authors:  M Sasaki; S Ehara; Y Tamakawa; S Takahashi; H Tohgi; A Sakai; T Mita
Journal:  AJNR Am J Neuroradiol       Date:  1995 Nov-Dec       Impact factor: 3.825

9.  Basal forebrain neurons in the dementia of Parkinson disease.

Authors:  P J Whitehouse; J C Hedreen; C L White; D L Price
Journal:  Ann Neurol       Date:  1983-03       Impact factor: 10.422

10.  Neocortical cholinergic neurons in elderly people.

Authors:  P White; C R Hiley; M J Goodhardt; L H Carrasco; J P Keet; I E Williams; D M Bowen
Journal:  Lancet       Date:  1977-03-26       Impact factor: 79.321

View more
  8 in total

1.  Human subthalamic nucleus: evaluation with high-resolution MR imaging at 3.0 T.

Authors:  Mika Kitajima; Yukunori Korogi; Shingo Kakeda; Junji Moriya; Norihiro Ohnari; Toru Sato; Yoshiko Hayashida; Toshinori Hirai; Tomoko Okuda; Yasuyuki Yamashita
Journal:  Neuroradiology       Date:  2008-04-29       Impact factor: 2.804

2.  Thalamic Dorsomedial Nucleus Free Water Correlates with Cognitive Decline in Parkinson's Disease.

Authors:  Thomas Guttuso; Daniel Sirica; Duygu Tosun; Robert Zivadinov; Ofer Pasternak; Daniel Weintraub; Francesca Baglio; Niels Bergsland
Journal:  Mov Disord       Date:  2021-12-22       Impact factor: 10.338

Review 3.  The Cholinergic Brain in Parkinson's Disease.

Authors:  Jacopo Pasquini; David J Brooks; Nicola Pavese
Journal:  Mov Disord Clin Pract       Date:  2021-08-23

4.  New MRI Biomarkers Advance the Characterization of Parkinson Disease.

Authors:  David A Ziegler; Suzanne Corkin
Journal:  Eur Neurol Rev       Date:  2013

5.  Harnessing advances in structural MRI to enhance research on Parkinson's disease.

Authors:  David A Ziegler; Jean C Augustinack
Journal:  Imaging Med       Date:  2013-04

6.  Volumetric correlates of cognitive functioning in nondemented patients with Parkinson's disease.

Authors:  J Vincent Filoteo; Jason D Reed; Irene Litvan; Deborah L Harrington
Journal:  Mov Disord       Date:  2013-09-03       Impact factor: 10.338

7.  Substantia nigra volume loss before basal forebrain degeneration in early Parkinson disease.

Authors:  David A Ziegler; Julien S Wonderlick; Paymon Ashourian; Leslie A Hansen; Jeremy C Young; Alex J Murphy; Cecily K Koppuzha; John H Growdon; Suzanne Corkin
Journal:  JAMA Neurol       Date:  2013-02       Impact factor: 18.302

8.  Analysis of the substantia innominata volume in patients with Parkinson's disease with dementia, dementia with lewy bodies, and Alzheimer's disease.

Authors:  Hee Jin Kim; Ji Eun Lee; Soo Jeong Shin; Young Ho Sohn; Phil Hyu Lee
Journal:  J Mov Disord       Date:  2011-10-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.